Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial.

uu.nl.AbstractBACKGROUND: Phobic anxiety disorders are among the most prevalent psychiatric disorders and are burdensome in terms of loss of quality of life and work productivity. Evidence-based treatments are relatively successful in the majority of patients, especially exposure therapy. However, a substantial subset of patients fails to achieve or stay in Read more…

Partage le savoir

Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial.

uu.nl.AbstractBACKGROUND : Troubles anxieux phobiques sont parmi les troubles psychiatriques les plus répandus et sont lourdes en termes de perte de qualité de vie et la productivité de travail. Les traitements fondées sur des preuves sont relativement réussies dans la majorité des patients, la thérapie d’exposition notamment. Toutefois, un sous-ensemble important Read more…

Partage le savoir

Exogenous progesterone for cannabis withdrawal in women: Feasibility trial of a novel multimodal methodology.

musc.edu.2Department of Psychology, Auburn University, 226 Thach Hall, AL 36849, USA.3Department of Psychiatry and Behavioral Sciences, Medical Unviersity of South Carolina, 67 President Street, Charleston, SC 29425, USA; Ralph H. Johnson VAMC, 109 Bee Street, Charleston, SC 29401, USA.AbstractBACKGROUND: Sex differences in cannabis use disorder (CUD) and its treatment have Read more…

Partage le savoir
error: Content is protected !!